413965924	413965924	CD	B-NP	O
|	|	NNP	I-NP	O
WH	WH	NNP	I-NP	O
|	|	VBD	B-VP	O
65402641	65402641	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9910065	9910065	CD	B-NP	O
|	|	CC	I-NP	O
1/7/2006	1/7/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
liver	liver	NN	I-NP	O
cyst	cyst	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/18/2006	8/18/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/6/2006	7/6/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
MASCETTI	MASCETTI	NNP	B-NP	O
,	,	,	O	O
BRYANT	BRYANT	NNP	B-NP	O
C	C	NNP	I-NP	O
450-61-84-3	450-61-84-3	CD	I-NP	O
Sti	Sti	NNP	I-NP	O
Le	Le	NNP	I-NP	O
A	A	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
8/10/06	8/10/06	CD	B-NP	O
AT	AT	NN	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Stress	Stress	NNP	I-NP	O
test	test	NN	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SPIGELMAN	SPIGELMAN	NNP	B-NP	O
,	,	,	O	O
RODOLFO	RODOLFO	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
CHLORHEXIDINE	CHLORHEXIDINE	NN	I-NP	O
MOUTHWASH	MOUTHWASH	NN	I-NP	O
0.12	0.12	CD	B-NP	O
%	%	NN	I-NP	O
15	15	CD	B-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
BID	BID	NN	I-NP	O
NEURONTIN	NEURONTIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
GABAPENTIN	GABAPENTIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LEVOXYL	LEVOXYL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

OXAZEPAM	OXAZEPAM	IN	B-PP	O
20	20	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
OXYBUTYNIN	OXYBUTYNIN	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Primary	Primary	NNP	I-NP	O
care	care	NN	I-NP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Sara	Sara	NNP	I-NP	O
,	,	,	O	O
cardiology	cardiology	NN	B-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
rule	rule	VB	B-VP	O
out	out	RP	B-PRT	O
MI	MI	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
liver	liver	NN	I-NP	O
cyst	cyst	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
diet-controlled	diet-controlled	JJ	B-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
depression/anxiety	depression/anxiety	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
dyspepsia	dyspepsia	NN	I-NP	O
,	,	,	O	O
postmenopausal	postmenopausal	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
hereditary	hereditary	JJ	B-NP	O
spherocytosis	spherocytosis	NN	I-NP	O
,	,	,	O	O
OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
RUQ	RUQ	NNP	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
,	,	,	O	O
MRI	MRI	NN	B-NP	O
of	of	IN	B-PP	O
abdomen	abdoman	NNS	B-NP	O
,	,	,	O	O
MIBI	MIBI	NNP	B-NP	O
,	,	,	O	O
Cardiac	Cardiac	NNP	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
and	and	CC	O	O
telemetry	telemetry	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Chest/abd	Chest/abd	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-NP	O
73	73	CD	I-NP	O
yo	yo	NN	I-NP	O
female	female	JJ	B-ADJP	O
with	with	IN	B-PP	O
past	past	JJ	B-NP	O
tob	tob	NN	I-NP	O
,	,	,	O	O
MIBI	MIBI	NNP	B-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
reversible	reversible	JJ	B-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
LAD	LAD	NN	B-NP	B-protein
territory	territory	NN	I-NP	I-protein
6/8	6/8	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
conservatively	conservatively	RB	B-NP	I-protein
managed	manage	VBN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Had	Have	VBD	B-VP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
after	after	IN	B-PP	O
dinner	dinner	NN	B-NP	O
lasting	last	VBG	B-VP	O
15min	15min	NN	B-NP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Called	Call	VBN	B-VP	O
EMS	EMS	NNP	B-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
in	in	IN	B-PP	O
abdominal/epigastric/substernal	abdominal/epigastric/substernal	JJ	B-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

Reports	Report	NNS	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
congestion	congestion	NN	B-NP	O
x1	x1	NN	I-NP	O
wk	wk	NN	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
+	+	SYM	B-VP	O
nitro	nitro	NN	B-NP	O
,	,	,	O	O
zofran	zofran	NN	B-NP	O
given	give	VBN	B-VP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
night	night	NN	I-NP	O
sweats	sweat	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
urine	urine	NN	B-NP	O
or	or	CC	I-NP	O
stool	stool	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	O
onset	onset	NN	I-NP	O
shortly	shortly	RB	B-ADVP	O
after	after	IN	B-PP	O
eating	eat	VBG	B-VP	O
sandwich	sandwich	NN	B-NP	O
.	.	.	O	O

Known	Know	VBN	B-NP	O
history	history	NN	I-NP	O
gallstones	gallstone	NNS	I-NP	O
.	.	.	O	O

****************	****************	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
dyslipedemia	dyslipedemia	NN	B-NP	O
,	,	,	O	O
hypothyroid	hypothyroid	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
irritable	irritable	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
bipolar	bipolar	JJ	B-NP	O
,	,	,	I-NP	O
hemolytic	hemolytic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
hepatic	hepatic	JJ	B-NP	O
cyst	cyst	NN	I-NP	O
.	.	.	O	O

****************	****************	SYM	O	O
Pre-admission	Pre-admission	NN	B-NP	O
Medication	Medication	NNP	I-NP	O
List	List	NNP	I-NP	O
for	for	IN	B-PP	O
MUTERSPAW	MUTERSPAW	NNP	B-NP	O
,	,	,	O	O
NICKY	NICKY	NNP	B-NP	O
B	B	NNP	I-NP	O
65402641	65402641	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BHC	BHC	NN	I-NP	B-protein
-RRB-	-RRB-	IN	B-PP	I-protein
73	73	CD	B-NP	I-protein
F	F	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

Acetylsalicylic	Acetylsalicylic	JJ	B-NP	O
Acid	Acid	NN	I-NP	O
PO	PO	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Apap	Apap	IN	B-PP	O
500mg	500mg	CD	B-NP	O
+	+	SYM	I-NP	O
Diphenhydramine	Diphenhydramine	NN	I-NP	O
25mg	25mg	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
Tylenol	Tylenol	NN	I-NP	O
Pm	Pm	NN	I-NP	O
-RRB-	-RRB-	SYM	B-VP	O
PO	PO	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
QHS	QHS	NN	I-NP	I-protein
prn	prn	NN	I-NP	I-protein
insomnia	insomnia	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Gabapentin	Gabapentin	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
1200	1200	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Levothyroxine	Levothyroxine	NNP	B-NP	O
Sodium	Sodium	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Levoxyl	Levoxyl	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
25	25	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
QD	QD	NNP	I-NP	O
please	please	NN	I-NP	O
restart	restart	VB	B-VP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Metoprolol	Metoprolol	NNP	B-NP	O
Succinate	Succinate	NNP	I-NP	O
Extended	Extended	NNP	I-NP	O
Release	Release	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Toprol	Toprol	NNP	I-NP	O
Xl	Xl	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
GTUBE	GTUBE	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Oxazepam	Oxazepam	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Serax	Serax	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
QHS	QHS	NNP	I-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Oxybutynin	Oxybutynin	NN	B-NP	O
Chloride	Chloride	NN	I-NP	O
PO	PO	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Simvastatin	Simvastatin	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Zocor	Zocor	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
*****************	*****************	NNP	I-NP	O
PE	PE	NNP	I-NP	O
:	:	:	O	O
T97	T97	NN	B-NP	O
.1	.1	NN	I-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
81	81	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
162/68	162/68	CD	I-NP	I-DNA
,	,	,	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
&	&	CC	I-NP	B-DNA
O	O	NN	I-NP	I-DNA
x3	x3	NN	I-NP	I-DNA
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
Lungs	Lung	VBZ	B-VP	O
CTA	CTA	NN	B-NP	O
b/l	b/l	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
RRR	RRR	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
M/R/G	M/R/G	NNP	I-NP	O
Abd	Abd	NNP	I-NP	O
:	:	:	O	O
Obese	Obese	NN	B-NP	O
,	,	,	O	O
RUQ	RUQ	NN	B-NP	B-protein
mildly	mildly	RB	I-NP	O
tender	tender	NN	I-NP	O
,	,	,	O	O
Ext	Ext	NNP	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
C/C/E	C/C/E	NN	I-NP	B-protein
*****************	*****************	SYM	B-ADJP	I-protein
Labs	Lab	NNPS	B-NP	O
:	:	:	O	O
Hct	Hct	NN	B-NP	O
33.9	33.9	CD	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
enz	enz	NN	I-NP	O
neg	neg	NN	I-NP	O
x3	x3	NN	I-NP	O
RUQ	RUQ	NN	I-NP	O
u/s	u/	NNS	I-NP	O
large	large	JJ	B-NP	O
complex	complex	JJ	I-NP	O
liver	liver	NN	I-NP	O
cyst	cyst	NN	I-NP	O
MRI	MRI	NN	I-NP	O
:	:	:	O	O
8	8	CD	B-NP	O
cm	cm	NN	I-NP	O
complex	complex	NN	I-NP	O
cystic	cystic	JJ	I-NP	O
hepatic	hepatic	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
enhancement	enhancement	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
the	the	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
location	location	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
likely	likely	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
biliary	biliary	JJ	I-NP	O
cystadenoma	cystadenoma	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
entities	entity	NNS	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
differential	differential	JJ	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
including	include	VBG	B-PP	O
biliary	biliary	JJ	B-NP	O
cystadenocarcinoma	cystadenocarcinoma	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
thrombosed	thrombose	VBN	I-NP	O
hemangioma	hemangioma	NN	I-NP	O
,	,	,	O	O
cystic	cystic	JJ	B-NP	B-protein
metastases	metastasis	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
infection	infection	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
hydatid	hydatid	NN	I-NP	O
or	or	CC	O	O
abscess	abscess	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
available	available	JJ	B-ADJP	O
,	,	,	O	O
access	access	NN	B-NP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
prior	prior	JJ	I-NP	O
outside	outside	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
helpful	helpful	JJ	B-ADJP	O
to	to	TO	B-VP	O
distinguish	distinguish	VB	I-VP	O
these	these	DT	B-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
follow-up	follow-up	NN	B-NP	O
or	or	CC	I-NP	O
biopsy	biopsy	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

Nonenhancing	Nonenhance	VBG	B-VP	O
cystic	cystic	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
spleen	spleen	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
a	a	DT	I-NP	O
splenic	splenic	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
or	or	CC	I-NP	O
hemangioma	hemangioma	NN	I-NP	O
.	.	.	O	O

*****************	*****************	SYM	O	O
Hospital	Hospital	NN	B-NP	O
Course	Course	NN	I-NP	O
:	:	:	O	O
73	73	CD	B-NP	O
yo	yo	NN	I-NP	O
with	with	IN	B-PP	O
probable	probable	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
abd/chest	abd/chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Was	Was	NNP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
f/u	f/u	NN	B-NP	O
MIBI	MIBI	NNP	I-NP	O
actually	actually	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
interval	interval	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
epigastric	epigastric	JJ	B-ADJP	O
in	in	IN	B-PP	O
location	location	NN	B-NP	O
,	,	,	O	O
pursued	pursue	VBN	B-VP	O
further	further	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
of	of	IN	B-PP	O
liver	liver	NN	B-NP	O
cyst	cyst	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
R/o	R/o	NN	B-NP	O
by	by	IN	B-PP	O
negative	negative	JJ	B-NP	O
enzymes	enzyme	NNS	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
BB	BB	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
following	follow	VBG	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Stress	Stress	NN	B-NP	O
PET	PET	NN	I-NP	O
on	on	IN	B-PP	O
6/26	6/26	CD	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
any	any	DT	B-NP	O
reversible	reversible	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
unlike	unlike	IN	B-PP	O
prior	prior	JJ	B-NP	O
study	study	NN	I-NP	O
6/8	6/8	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
continue	continue	VB	I-VP	O
current	current	JJ	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
elevated	elevated	JJ	I-NP	O
BP	BP	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
on	on	IN	B-PP	O
25	25	CD	B-NP	O
lopressor	lopressor	NN	I-NP	O
TID	TID	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
increase	increase	VB	I-VP	O
toprol	toprol	NN	B-NP	O
from	from	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
50mg	50mg	CD	I-NP	O
PO	PO	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
should	should	MD	B-VP	O
followup	followup	VB	I-VP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
and	and	CC	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
adjustments	adjustment	NNS	I-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Largo	Largo	NNP	I-NP	O
was	be	VBD	B-VP	O
notified	notify	VBN	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Abd	Abd	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
abdominal	abdominal	JJ	B-NP	O
component	component	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
given	give	VBN	B-VP	O
absence	absence	NN	B-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
more	more	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
originated	originate	VBN	B-VP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
biliary	biliary	JJ	B-NP	O
or	or	CC	I-NP	O
hepatic	hepatic	JJ	I-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
PPI	PPI	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
RUQ	RUQ	NN	I-NP	O
u/s	u/	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
small	small	JJ	B-NP	O
gallstones	gallstone	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
sizable	sizable	JJ	I-NP	O
hepatic	hepatic	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
previously	previously	RB	B-VP	O
known	know	VBN	I-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
cyst	cyst	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
MRI	MRI	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
likely	likely	RB	B-NP	O
cystadenoma	cystadenoma	NN	I-NP	O
per	per	IN	B-PP	O
preliminary	preliminary	JJ	B-NP	O
report	report	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
lesion	lesion	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
closely	closely	RB	I-VP	O
followed	follow	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
surgical	surgical	JJ	B-NP	O
options	option	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
biliary	biliary	JJ	B-NP	O
pain	pain	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
given	give	VBN	B-PP	O
presence	presence	NN	B-NP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
gallstones	gallstone	NNS	I-NP	O
and	and	CC	O	O
timing	timing	NN	B-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

Referral	Referral	JJ	B-ADJP	O
for	for	IN	B-PP	O
elective	elective	JJ	B-NP	O
laproscopic	laproscopic	JJ	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
.	.	.	O	O

depression/anxiety/bipolar	depression/anxiety/bipolar	JJ	B-ADJP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
.	.	.	O	O

Anemia	Anemia	NNP	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-ADJP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Should	Should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Reported	Report	VBN	B-NP	O
h/o	h/o	NN	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

A1C	A1C	NN	B-NP	B-protein
was	be	VBD	B-VP	O
4.5	4.5	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hyperthyroidism	Hyperthyroidism	NN	B-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
levoxyl	levoxyl	NN	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
2.808	2.808	CD	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Periodontal	Periodontal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
reported	report	VBD	B-VP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
gums	gum	NNS	B-NP	O
,	,	,	O	O
?	?	.	O	O

infection	infection	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
offered	offer	VBN	I-VP	O
chlorhexidine	chlorhexidine	NN	B-NP	O
mouthwash	mouthwash	NN	I-NP	O
and	and	CC	O	O
encouraged	encourage	VBD	B-VP	O
to	to	TO	I-VP	O
followup	followup	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
dentist	dentist	NN	I-NP	O
as	as	RB	B-ADVP	O
soon	soon	RB	I-ADVP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-ADJP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
.	.	.	O	O

Full	Full	NNP	B-NP	O
Code	Code	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-PP	O
prior	prior	JJ	B-ADJP	O
,	,	,	O	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
take	take	VB	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
higher	high	JJR	I-NP	O
dose	dose	NN	I-NP	O
until	until	IN	B-PP	O
talking	talk	VBG	B-VP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
cyst	cyst	NN	I-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
liver	liver	NN	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
to	to	TO	B-VP	O
discuss	discuss	VB	I-VP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
or	or	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
seek	seek	VB	B-VP	O
medical	medical	JJ	B-NP	B-protein
attention	attention	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Seek	Seek	VB	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
dentist	dentist	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
gums	gum	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Hepatobiliary	Hepatobiliary	JJ	B-NP	O
cystadenoma	cystadenoma	NN	I-NP	O
:	:	:	O	O
could	could	MD	B-VP	O
consider	consider	VB	I-VP	O
surgical	surgical	JJ	B-NP	O
excision	excision	NN	I-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
gallbladder	gallbladder	NN	B-NP	B-protein
removal	removal	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Follow	Follow	JJ	B-NP	B-protein
BP	BP	NN	I-NP	I-protein
,	,	,	O	O
as	as	IN	B-SBAR	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	B-PP	O
50mg	50mg	CD	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
OBERLIES	OBERLIES	NNP	B-NP	O
,	,	,	O	O
ODELL	ODELL	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RZ63	RZ63	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/10/06	8/10/06	CD	I-NP	O
@	@	SYM	B-NP	O
05	05	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

